-
2023-509421-41-03
5
Bacterial vaginosis
-
2024-513724-42-00
10
Medulloblastoma
-
2024-515714-40-00
4
Gout adult patients
-
2024-516335-27-00
5
anti-MAG neuropathy
-
2024-519783-41-00
4
sepsis
-
2024-519894-20-01
5
Adult with an staphylococcal prosthetic joint infection treated with d
-
2025-520976-25-00
4
Relapsed/refractory multiple myeloma
-
2025-520995-24-00
5
Adult patients treated for haematological disorders, in whom chemother
-
2025-523539-20-00
4
Low Grade Upper Tract Urothelial Carcinoma
-
2025-520979-13-00
5
2025-12-18
Patients with HR+ HER2- early breast cancer at intermediate risk of re
-
2025-521755-23-00
5
2026-04-28
Respiratory syncytial virus infection
-
2024-517996-19-00
4
2025-06-19
Primary premature ejaculation
-
2023-507666-32-00
4
2025-05-27
Inclusion body Myositis
-
2023-508260-30-01
5
2024-07-30
Patients with poor prognostic OVARian cancers based on the tumor prima
-
2023-503317-29-00
5
2024-04-12
Metastatic renal cell carcinoma (mRCC)
-
2023-508531-30-00
4
2024-03-25
grade 1 glioma/mixed glio-neuronal tumors or pleomorphic xanthoastrocy
-
2024-515146-16-00
5
2023-05-15
Colorectal surgery
-
2023-503481-23-00
5
2023-03-20
Maintenance treatment in metastatic non-squamous lung cancer
-
2024-515945-40-00
10
2022-05-02
Non small cell lung cancer
-
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
-
2024-514637-37-00
5
2020-02-11
Patients with bone sarcomas other than chordoma, who have no residual
-
2024-512629-97-00
4
2019-01-23
Patients with locally advanced or metastatic low grade endometrial str
-
2024-516110-38-00
5
2018-03-06
Hepatoblastoma and Hepatocellular Carcinoma
-
2024-517275-21-00
4
2012-02-20
Retinoblastoma